Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dizal (Jiangsu) Pharmaceutical Co. Ltd. A

688192
Current price
44.71 CNY -0.31 CNY (-0.69%)
Last closed 45.34 CNY
ISIN unknown
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Shanghai Stock Exchange
Capitalization 19 542 826 718 CNY
Yield for 12 month +1.52 %
1Y
3Y
5Y
10Y
15Y
688192
21.11.2021 - 28.11.2021

Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases. It develops JAUKPO, which is in Phase II clinical trials for the treatment of hematological malignancy and immunological diseases; DZD8586 that is in Phase I for the treatment of hematological malignancy; ZEGFROVY, which is in Phase II clinical trials for the treatment of solid tumors; DZD1516 that is in Phase II clinical trials for the treatment of solid tumors; and DZD2269, which is in Phase I clinical trials for the treatment of solid tumors. The company was founded in 2017 and is based in Shanghai, China. Address: 199 Liangjing Rd, Shanghai, China, 201203

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

390.56 CNY

P/E ratio

Dividend Yield

Current Year

+91 555 740 CNY

Last Year

Current Quarter

+122 589 197 CNY

Last Quarter

+81 556 491 CNY

Current Year

+88 331 586 CNY

Last Year

Current Quarter

+119 867 578 CNY

Last Quarter

+79 493 803 CNY

Key Figures 688192

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -926 950 997 CNY
Operating Margin TTM -138.73 %
PE Ratio
Return On Assets TTM -36.32 %
PEG Ratio
Return On Equity TTM -122.2 %
Wall Street Target Price 390.56 CNY
Revenue TTM 390 777 297 CNY
Book Value 1.05 CNY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 236.4 %
Dividend Yield
Gross Profit TTM -2 653 472 CNY
Earnings per share -2.05 CNY
Diluted Eps TTM -2.05 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -214.87 %

Dividend Analytics 688192

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 688192

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 688192

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 50.2556
Price Sales TTM 50.4582
Enterprise Value EBITDA -24.9831
Price Book MRQ 45.4815

Financials 688192

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 688192

For 52 weeks

24.89 CNY 54.74 CNY
50 Day MA 40.58 CNY
Shares Short Prior Month
200 Day MA 40.04 CNY
Short Ratio
Shares Short
Short Percent